Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-06044-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Francesca Huwyler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Induction Chemotherapy, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bern.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
Induction chemotherapy (IC) for patients with locally advanced stage Head and Neck Squamous Cell Carcinomas (HNSCC) before radio-chemotherapy (RCT) or surgery remains a potential treatment option. This study analyzed how the response to IC correlates with survival outcomes.
Methods
We conducted a retrospective single-center study at a tertiary cancer center. Tumors were categorized by anatomical site and response to IC (non-responders vs. responders). Data were analyzed using Kaplan-Meier survival curves and Cox regression analysis.
Results
A total of 48 patients received IC. Of these, 33 patients were radiologically evaluable for response. The majority of evaluable patients received either TPF (Docetaxel, Cisplatin, 5-Fluorouracil) (58%) or TP (Docetaxel, Cisplatin) (24%) as their IC regimen. Tumor reduction of 30% or more was observed in 23 patients (69.7%), the tumor control rate was 97%. The 2-year event-free survival (EFS) in the IC evaluable population was 53.1%, overall survival (OS) was 63.6%, and recurrence-free survival (RFS) was 62.5%. Patients with laryngeal or hypopharyngeal tumors that did not respond to IC had a significantly poorer prognosis. This effect was not statistically significant in tumors of the oral cavity or oropharynx, where it was only observed as a trend.
Conclusion
IC is highly effective in treating locally advanced stage HNSCC. The response to IC is prognostic for survival, particularly in cancers of the larynx and hypopharynx.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Otorhinolaryngology, Head and Neck Surgery, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
- Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. simon.haefliger@insel.ch.
ORCID-Profile: Simon Haefliger
Förderung
- University of Bern
Zitieren
APA
Huwyler, F., Giger, R., Bill, R., Rauch, D., & Haefliger, S. (2024). Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-06044-2
Vancouver
Huwyler F, Giger R, Bill R, Rauch D, Haefliger S. Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-06044-2
BibTeX
@article{Huwyler2024,
author = {Huwyler, Francesca and Giger, Roland and Bill, Ruben and Rauch, Daniel and Haefliger, Simon},
title = {Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-06044-2}
}
EUVIMED